Connect with us

Hi, what are you looking for?

Jewish Business News


EndoChoice raises $96 million in NYSE IPO

The main beneficiary of the medical device company’s IPO was Mori Arkin and Uri Geiger’s Accelmed with a 9% stake.

Mori Arkin

US-Israeli medical equipment company EndoChoice Holdings Inc.(NYSE:GI) last Friday raised $96 million on the New York Stock Exchange at a company value of $366 million, after money. The offering was priced at the lower limit of the range mentioned by the company – $15 a shEndoChoice Holdings Inc.(NYSE:GI) are. On the first trading day, however, the share price already rose to $17, giving the company a $415 million market cap.

An immediate rise in the share following pricing usually indicates pressure from the underwriters to lower the price, and that the company made a concession on its price in order to bring strong parties into the offering, even though demand outstripped supply. In this case, the demand for the flotation totaled $500 million-$1 billion…Read More

Published by Globes [online], Israel business news –



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.